Clinical trials: sponsored by Dana-Farber Cancer Institute
Uterine Cancer
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
This research study is studying an investigational drug as a possible treatment for uterine cancer. The drug involved in this study is: -AZD1775
- Trial name
- NCT03668340
- Testing
- AZD1775
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Dana-Farber Cancer Institute
Prostate Cancer, Hot Flashes
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
This is a prospective, randomized, non-pharmacologic interventional trial evaluating the effectiveness of the Embr Wave wearable thermal device in reducing hot flash burden in men with prostate cancer receiving androgen…
- Conditions
- Prostate Cancer, Hot Flashes, Vasomotor Symptoms
- Trial name
- ReduceHEAT (NCT07729150)
- Testing
- Embr Wave
- Where
- United States
- Volunteers
- 66 people
- Sponsor
- Dana-Farber Cancer Institute
Breast Cancer
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
This research study is studying whether participants and their doctors are willing to determine post-surgery treatment on the basis of response to pre-surgery treatment, and studying blood and tissue collected from participants…
- Trial name
- NCT03716180
- Testing
- Paclitaxel, Trastuzumab, Pertuzumab
- Where
- 5 sites in United States
- Volunteers
- 100 people
- Sponsor
- Dana-Farber Cancer Institute
Osteosarcoma, Osteosarcoma Recurrent
Olaparib With Ceralasertib in Recurrent Osteosarcoma
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of…
- Trial name
- NCT04417062
- Testing
- Olaparib, Ceralasertib
- Where
- 4 sites in United States
- Volunteers
- 49 people
- Sponsor
- Dana-Farber Cancer Institute
Stage I Breast Cancer, Stage II Breast Cancer
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PALB2 mutations.
- Conditions
- Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Breast Cancer
- Trial name
- NCT04584255
- Testing
- Niraparib, Dostarlimab
- Where
- 8 sites in United States
- Volunteers
- 66 people
- Sponsor
- Dana-Farber Cancer Institute
Chemotherapy-induced Peripheral Neuropathy, Nerve Pain
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
The purpose of this study is to test whether yoga can reduce nerve pain caused by cancer treatment (chemotherapy-induced peripheral neuropathy, or CIPN).
- Conditions
- Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy, Neuropathy, Painful
- Trial name
- YCT (NCT05121558)
- Testing
- Yoga, Education control, Usual care
- Where
- 8 sites in United States
- Volunteers
- 227 people
- Sponsor
- Dana-Farber Cancer Institute
Prostate Cancer, Cardiovascular Diseases
CV CARE: CardioVascular Care in PC Patients
This research is being done to test a program to assess and manage reversible cardiovascular (CV) risk factors in participants with prostate cancer starting androgen deprivation therapy (ADT), with the goal of integrating a…
- Trial name
- NCT06202820
- Testing
- CV Care Program
- Where
- 2 sites in United States
- Volunteers
- 180 people
- Sponsor
- Dana-Farber Cancer Institute
Chemotherapy Induced Peripheral Neuropathy (CIPN), Peripheral Neuropathy Due to Chemotherapy
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced…
- Conditions
- Chemotherapy Induced Peripheral Neuropathy (CIPN), Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathies, Neuropathy
- Trial name
- NCT06807294
- Testing
- Tai Chi Program
- Where
- United States
- Volunteers
- 21 people
- Sponsor
- Dana-Farber Cancer Institute
Chronic Lymphocytic Leukemia
A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
This research study is evaluating a combination of two drugs, ibrutinib and obinutuzumab, as a possible treatment for Chronic Lymphocytic Leukemia (CLL).
- Trial name
- NCT02537613
- Testing
- Obinutuzumab, Ibrutinib
- Where
- 4 sites in United States
- Volunteers
- 52 people
- Sponsor
- Dana-Farber Cancer Institute
Pediatric Solid Tumor
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
This research study is evaluating the use of specialized testing of solid tumors including sequencing. The process of performing these specialized tests is called tumor profiling.
- Trial name
- NCT02520713
- Testing
- Genetic testing and GAIN report
- Where
- 12 sites in United States
- Volunteers
- 825 people
- Sponsor
- Dana-Farber Cancer Institute
Low Grade Ovarian Serous Adenocarcinoma, Endometrial Cancer
Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial
This is a phase 2, interventional treatment trial evaluating imlunestrant, abemaciclib, and selinexor in two separate patient cohorts: low grade serous ovarian cancer and endometrioid endometrial cancer.
- Trial name
- SIERRA (NCT07832227)
- Testing
- Imlunestrant, Abemaciclib, Selinexor
- Volunteers
- 60 people
- Sponsor
- Dana-Farber Cancer Institute
Advanced Cancer, Cancer Pain
Healing Gardens: Leveraging Serious Games to Deliver Accessible Pain-CBT and Pharmacologic Support for Patients With Advanced Cancer Managing Pain
This study is being done to determine the feasibility and acceptability of Healing Gardens, a standalone mobile health serious game designed to deliver pain-CBT and cancer pain education to help patients with advanced cancer…
- Conditions
- Advanced Cancer, Cancer Pain, Chronic Pain
- Trial name
- NCT07825051
- Testing
- Healing Gardens content development/refinement activities, Healing Gardens serious game
- Where
- 2 sites in United States
- Volunteers
- 46 people
- Sponsor
- Dana-Farber Cancer Institute
Cancer
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs).
- Trial name
- ACTIVATE (NCT07232043)
- Testing
- MatchMiner-AI Artificial Intelligence Tool
- Where
- United States
- Volunteers
- 70,000 people
- Sponsor
- Dana-Farber Cancer Institute
Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
This study is looking at the effects of Ipilimumab when it is given alone or in combination with Nivolumab to patients with relapsed or refractory classic Hodgkin's lymphoma (cHL).
- Conditions
- Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma
- Trial name
- NCT04938232
- Testing
- Nivolumab, Ipilimumab
- Where
- 4 sites in United States
- Volunteers
- 13 people
- Sponsor
- Dana-Farber Cancer Institute
Childhood Cancer, Childhood Cancer Survivors
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
The goal of the Cardiovascular Health Equity Through Food (CHEF) program is to make it easier for participants and families to cook and eat healthy foods during and following childhood cancer treatment with the long-term goal of…
- Trial name
- CHEF (NCT06609473)
- Testing
- CHEF Intervention Program
- Where
- 2 sites in United States
- Volunteers
- 17 people
- Sponsor
- Dana-Farber Cancer Institute
Muscle-Invasive Bladder Carcinoma, Bladder Cancer
Bladder Preservation or Cystectomy for MIBC
In this research study, investigators will assess whether it is feasible to use information from the genes of a tumor combined with evaluation of the tumor response to systemic therapy to determine if bladder sparing…
- Conditions
- Muscle-Invasive Bladder Carcinoma, Bladder Cancer, Urothelial Carcinoma
- Trial name
- NCT07821177
- Testing
- Gemzar, Cisplatin, Adrucil
- Where
- 2 sites in United States
- Volunteers
- 20 people
- Sponsor
- Dana-Farber Cancer Institute
Metastatic Breast Cancer
Palbociclib After CDK and Endocrine Therapy (PACE)
This research study is studying three combinations of drugs as treatments for breast cancer. The drugs involved in this study are: Fulvestrant Fulvestrant with Palbociclib Fulvestrant with Palbociclib and Avelumab
- Trial name
- NCT03147287
- Testing
- Palbociclib, Fulvestrant, Avelumab
- Where
- 22 sites in United States
- Volunteers
- 220 people
- Sponsor
- Dana-Farber Cancer Institute
Colorectal Cancer, Metastatic Colon Cancer
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
This research study is a randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing…
- Conditions
- Colorectal Cancer, Metastatic Colon Cancer, Metastatic Colorectal Cancer
- Trial name
- NCT06202183
- Testing
- Exercise Program
- Where
- United States
- Volunteers
- 84 people
- Sponsor
- Dana-Farber Cancer Institute
PROSTATE CANCER, Metastatic Prostate Cancer
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and…
- Conditions
- PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma
- Trial name
- NCT06040125
- Testing
- Supervised Circuit Training
- Where
- 3 sites in United States
- Volunteers
- 80 people
- Sponsor
- Dana-Farber Cancer Institute
Gastric Cancer, Colon Cancer
Resilience and Equity in Aging, Cancer, and Health (REACH)
The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
- Conditions
- Gastric Cancer, Colon Cancer, Esophageal Cancer, Rectal Cancer
- Trial name
- REACH (NCT04674267)
- Testing
- Phase 2 Intervention - Geriatric Co-Management
- Where
- United States
- Volunteers
- 147 people
- Sponsor
- Dana-Farber Cancer Institute